Corporate strategy R&D and technology transfer in the European pharmaceutical industry: research findings

Discusses the extent to which American, European and Japanese pharmaceutical multinational enterprises (MNE) with subsidiaries in the Republic of Ireland have localised specific forms of R&D and contributed to technology transfer. Reports on a survey in which chief executive officers of Irish‐based MNE subsidiaries responded to mailed questionnaires. The reasons for corporate management to choose such operational strategic thrusts at business level have been highlighted with a view to focus on the degree to which Ireland is developing its pharmaceutical industrial base, as a result of attracting export‐led global pharmaceutical multinationals.